Translate the text from Welsh to English.



 
Heddiw, yn dilyn misoedd o drafod ac ystyried y dystiolaeth, mae’r Cyd\-bwyllgor ar Imiwneiddio a Brechu wedi rhoi cyngor ar frechu plant a phobl ifanc 12\-15 oed. 


Maent yn argymell estyn y rhestr o gyflyrau iechyd penodol ar gyfer plant a phobl ifanc 12 \- 15 oed sy’n gymwys ar gyfer dau ddos o’r brechlyn COVID\-19\. Mae eu cyngor yn nodi’r grwpiau ychwanegol a fydd yn gymwys. Bydd ein Gwasanaeth Iechyd Gwladol yn gweithio’n gyflym i nodi’r plant a’r bobl ifanc hyn, a bydd eu Byrddau Iechyd yn cysylltu â hwy yn awtomatig. Nid oes angen i gleifion gysylltu â’u Byrddau Iechyd nac â chlinigwyr i wirio a ydynt yn gymwys. Bydd y plant a’r bobl ifanc hynny sydd eisoes yn gymwys yn unol â chyngor y Cyd\-bwyllgor ynghylch cyflyrau iechyd penodol, wedi cael cynnig apwyntiadau erbyn hyn.


O ran plant a phobl ifanc 12\-15 oed nad oes ganddynt gyflyrau iechyd sy’n bodoli eisoes, mae’r Cyd\-bwyllgor wedi cynghori bod manteision brechu ychydig yn fwy na’r niwed posibl y gwyddom amdano, ond bod ansicrwydd sylweddol o ran maint y niwed hwn. O safbwynt manteision iechyd i unigolion, nid yw’r Cyd\-bwyllgor ar hyn o bryd yn credu bod y manteision yn ddigon i gefnogi cyngor ar gyfer rhaglen frechu gyffredinol i blant 12\-15 oed sy’n iach fel arall. Fodd bynnag, maent yn cydnabod bod materion ehangach i’w hystyried, materion nad yw’r Cyd\-bwyllgor yn gyfrifol am eu gwerthuso o fewn ei gylch gwaith. Er enghraifft, effeithiau strwythurol ehangach, gan gynnwys manteision addysgol, lle byddai’r Prif Swyddog Meddygol mewn sefyllfa well i roi cyngor, gyda sylwadau gan y Cyd\-bwyllgor.   


Hoffwn ddiolch i’r Cyd\-bwyllgor am roi ystyriaeth lawn i’r mater o frechu plant a phobl ifanc 12\-15 oed, ac am gymryd gofal er mwyn ffurfio safbwynt cytbwys. Ochr yn ochr â gwledydd eraill y DU, rwyf wedi gofyn i fy Mhrif Swyddog Meddygol ddarparu canllawiau cyn gynted â phosibl ar y manteision clinigol a’r manteision iechyd ehangach sy’n gysylltiedig â brechu’r grŵp oedran hwn. Ein bwriad, fel ein bwriad ers dechrau’r pandemig, yw dilyn y dystiolaeth glinigol a’r dystiolaeth wyddonol. Bydd penderfyniadau ar frechu pob plentyn a pherson ifanc 12\-15 oed yn cael eu gwneud ar sail cyngor y Prif Swyddog Meddygol, ynghyd â chyngor a ddarperir gan y Cyd\-bwyllgor. Yn y cyfamser, mae ein Gwasanaeth Iechyd Gwladol wedi cynllunio ar gyfer unrhyw benderfyniadau pellach a wneir ac yn barod i weithredu arnynt.


Mae'r datganiad hwn yn cael ei gyhoeddi yn ystod y toriad er mwyn rhoi'r wybodaeth ddiweddaraf i'r aelodau. Os bydd aelodau'n dymuno imi wneud datganiad pellach neu ateb cwestiynau am y mater hwn pan fydd y Senedd yn dychwelyd, byddwn yn hapus i wneud hynny.







Translation:


 
Today, following months of discussion and consideration of evidence, the Joint Committee for Vaccination and Immunisation (JCVI) have issued advice on the vaccination of children and young people aged 12\-15\. 


They recommend an expansion of the list of specific underlying health conditions for children and young people aged 12 \-15 years who are eligible for two doses of COVID\-19 vaccine. In their advice, they detail the additional groups who will be eligible. Our NHS will work quickly to identify these children and young people and their Health Boards will automatically contact them. There is no need for patients to contact their health board or clinicians to check eligibility. Those children and young people already eligible under the JCVI’s advice of specific underlying health conditions will have already been offered appointments.


On children and young people aged 12\-15 who do not have underlying health conditions, the JCVI have advised that the benefits from vaccination are marginally greater than the potential known harms but that there is considerable uncertainty regarding the magnitude of the potential harms. From an individual health benefit perspective, they feel the margin of benefit, is considered too small to support advice on a universal programme of vaccination of otherwise healthy 12\-15\-year\-old children at this time. They do however acknowledge that there may be wider issues to consider which are outside the remit of the JCVI to evaluate, such as wider societal impacts, including educational benefits, where the CMO would be better placed to advise, with representation from JCVI.


I would like to thank the JCVI for fully considering the issue of vaccinating 12\-15 year olds and for taking the care to form a balanced view. Alongside the other nations of the UK, I have asked my Chief Medical Officer (CMO) to provide guidance at the earliest opportunity on the clinical and wider health benefits of vaccinating this age group. Our intention, as it has been from the start of the pandemic, is to follow the clinical and scientific evidence. Decisions on the vaccination of all 12\-15 year olds will be made on the basis of the CMO’s advice, in addition to the advice provided by the JCVI. In the meantime, our NHS has planned and stands ready to implement any further decisions taken.


This statement is being issued during recess in order to keep members informed. Should members wish me to make a further statement or to answer questions on this when the Senedd returns I would be happy to do so.